Wealth Management Partners »

Summit Therapeutics shares owned by Wealth Management Partners

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Wealth Management Partners from 13F filings

Historical chart of Wealth Management Partners investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Wealth Management Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Wealth Management Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $182k 44k 4.14
2023-12-31 $39k 15k 2.61

More positions owned by Wealth Management Partners

Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Gold Tr Ishares New (IAU)
First Tr Exchange-traded Dj Internt Idx (FDN)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Amazon (AMZN)
Vanguard Whitehall Fds High Div Yld (VYM)
Ishares Tr Core S&p Us Vlu (IUSV)
Exxon Mobil Corporation (XOM)
Ishares Tr Msci Usa Min Vol (USMV)
Ishares Tr Core S&p Scp Etf (IJR)

View all positions for Wealth Management Partners

Top funds holding Summit Therapeutics

Vanguard Group
Charles Schwab Investment Management
Steward Partners Investment Advisory
ALPS Advisors
Barclays
Bank of New York Mellon
Jpmorgan Chase & Co
Swiss National Bank
Goldman Sachs Group
UBS Group
Advisor Group Holdings
China Universal Asset Management
Rhumbline Advisers
CSS
Bank of America Corporation

View all funds holding Summit Therapeutics